These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients. Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460 [TBL] [Abstract][Full Text] [Related]
3. Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Aldrighetti L; Pulitanò C; Catena M; Arru M; Guzzetti E; Halliday J; Ferla G Ann Surg Oncol; 2009 May; 16(5):1254. PubMed ID: 19277788 [TBL] [Abstract][Full Text] [Related]
4. Fine needle biopsy of a patent umbilical vein thrombus demonstrates hepatocellular carcinoma. Livraghi T; Corti D; Sangalli G Diagn Imaging; 1983; 52(6):332-4. PubMed ID: 6315325 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Zhou J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ; Fan J Hepatogastroenterology; 2006; 53(68):275-80. PubMed ID: 16608039 [TBL] [Abstract][Full Text] [Related]
6. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
7. Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer? Shirabe K; Matsumata T; Adachi E; Maeda T; Shimada M; Taketomi A; Sugimachi K Hepatogastroenterology; 1995; 42(6):923-30. PubMed ID: 8847047 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis. Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Dohmen K; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma. Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775 [TBL] [Abstract][Full Text] [Related]
11. [Portal vein involvement by hepatocellular carcinoma: diagnosis with three-dimensional contrast-enhanced MR angiography]. Lin J; Zhou KR; Wang JH; Yan ZP Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):308-12. PubMed ID: 15854505 [TBL] [Abstract][Full Text] [Related]
13. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Pawlik TM; Delman KA; Vauthey JN; Nagorney DM; Ng IO; Ikai I; Yamaoka Y; Belghiti J; Lauwers GY; Poon RT; Abdalla EK Liver Transpl; 2005 Sep; 11(9):1086-92. PubMed ID: 16123959 [TBL] [Abstract][Full Text] [Related]
14. [Significance of typing of tumor thrombi in determination of treatment and assessment of prognosis of hepatocellular carcinoma with tumor thrombi in the portal vein]. Cheng SQ; Wu MC; Chen H; Shen F; Yang JH; Cong WM; Wang PJ; Zhao YX Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):3-5. PubMed ID: 14990146 [TBL] [Abstract][Full Text] [Related]
15. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Ikai I; Arii S; Kojiro M; Ichida T; Makuuchi M; Matsuyama Y; Nakanuma Y; Okita K; Omata M; Takayasu K; Yamaoka Y Cancer; 2004 Aug; 101(4):796-802. PubMed ID: 15305412 [TBL] [Abstract][Full Text] [Related]
16. Liver transplant for hepatocellular carcinoma: experience in a Saudi population. Allam N; Khalaf H; Fagih M; Al-Sebayel M Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240 [TBL] [Abstract][Full Text] [Related]
17. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]. Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766 [TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638 [TBL] [Abstract][Full Text] [Related]
19. [A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy]. Yoon I; Yim HJ; Kim JN; Park SM; Kim JH; Lee SH; Chung HH; Lee HS; Lee SW; Choi JH Korean J Hepatol; 2009 Mar; 15(1):90-5. PubMed ID: 19346790 [TBL] [Abstract][Full Text] [Related]
20. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. Ikai I; Hatano E; Hasegawa S; Fujii H; Taura K; Uyama N; Shimahara Y J Am Coll Surg; 2006 Mar; 202(3):431-8. PubMed ID: 16500247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]